Susquehanna Reiterates Positive on NVIDIA, $275 Price Target
- Rating
- Positive
- Unchanged
- Target
- $275
- Unchanged
- Upside
- +87%
- NVDA at $147 today
8th-highest of 38 current targets on NVIDIA, 21% above the $228 median. Susquehanna has reached 85% of its year-old targets (34 scored).

What the analyst said
Susquehanna analyst Christopher Rolland reiterated a Positive rating and $275.00 price target on NVIDIA (NASDAQ: NVDA).
“NVIDIA once again delivered significantly better results and guidance, beating our prior 3Q and 4Q estimates by an impressive ~$6.5B and ~$5B, respectively.
That said, revenues in the quarter included ~$2.4B of Hopper sales to China that were not previously included in the company’s CY3Q guidance.
Additionally, there was a 14th week to be included in the fourth quarter. More importantly though, NVIDIA once again increased its guidance for FY28. Namely, the company now expects to grow 75% YOY (and on a higher base given the stronger 4Q guide), implying ~$40B of upside.
To meet its outsized growth expectations, the company increased its supply commitment by roughly ~$110B (now ~$390B), with investments mostly centered on securing additional HBM capacity.
Turning to CY3Q, Hyperscale results were ~$8B better than our expectations, offsetting -$2 billion weaker results in ACIE (interestingly, Hyperscale outgrew ACIE, contrary to the company’s guidance). The early ramp of Rubin also contributed to the better results as sales here ramped to ~ $20B in a single quarter (although this was a tad less than we had expected).
Meanwhile, Blackwell Ultra also grew sequentially in CY3Q. Promisingly, the company broadly reaffirmed its roadmap over the coming years, spanning CPO scale out (2H26), Rubin Ultra next year (2027), and Feynman (2028). Despite current market skepticism around the sustainability of AI investments, neocloud financing, and access to LPS, interim CEO Colette Kress seemed to broadly reiterate the company’s views under the Jensen regime.
As a testament to the inflection in demand that the company is seeing, management noted that B300 cloud pricing had increased by ~60% QOQ in 3Q (we called out a doubling in spot pricing for B300 in our 3Q26 AI-SIGnals note here). Beyond the top line, gross margins were 90 bps better than we had expected, though the better results may have been due to the shipment of previously written-down Hopper SKUs into China.
CY4Q GMs were guided to decline 340bps due to the ramp of the Vera Rubin platform, roughly in line with our prior expectations. In all, this was a much-needed positive report that may assuage investors amid the ongoing upheaval in the AI industry.
That said, concern about LPS availability and financing in 2028 and beyond are unlikely to fully wind down. We reiterate our Positive rating and $275 price target (~16.5x C2027E EV/NOPAT).”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
NVDA trades at $147. The 38 analysts who set a target in the last 3 months range from $135 to $350, with a median of $228. This $275 target is 21% above the median.
12-month window: day 1 of 365, closes on November 18, 2027.
Track record
This callOpen: NVDA has not reached $275 yet. This 12-month target is scored on November 18, 2027.
Firm track recordSusquehanna: 85% of its 34 targets at least a year old were reached within 12 months (#3 of 29 firms); on NVIDIA, 2 of 2. Accuracy ranking →
Susquehanna on NVIDIA
Susquehanna price targets on NVIDIA
2 calls from May 12, 2026 to November 18, 2026. The target stayed at $275. The rating stayed Buy.
- November 18, 2026 This noteKept the $275 targetBuy$275
- May 12, 2026Earliest call shownBuy$275




